Connect your AI

Biodesix, Inc. BDSX Retained Earnings

Retained Earnings at other companies

NeoGenomicsNEO

-$450.91M-28.2%

VeracyteVCYT

-$348.92M+20.1%

Adaptive BiotechnologiesADPT

-$1.38B-3.7%

Personalis, Inc.PSNL

-$661.29M-16.9%

Guardant HealthGH

-$3.11B-16.2%

Tempus AI, Inc.TEM

-$2.52B-13.7%

Other financials

Income statement

Revenue$25.6M+42.3%

Operating income-$6.2M+32.1%

Net income-$7.8M+29.8%

EPS (diluted)-$0.81+46.7%

Balance sheet

Cash & equivalents$25.6M+45.3%

Total debt$71.6M+15.0%

Total equity$9.1M-17.4%

Total assets$94.6M+9.7%

Cash flow

Operating cash flow-$10.2M-18.2%

CapEx$81.0K+9.5%

Free cash flow-$10.2M-18.1%

Valuation

Market cap$233.52M+462%

Enterprise value$279.56M+198%

P/S2.4×+1.9×

Profitability

Operating margin-26%-7.5pp

Net margin-33.3%-9.3pp

FCF margin-26.8%-9.6pp

Returns & leverage

Return on equity-316.5%—

Debt / equity7.8×+2.2×

Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Biodesix, Inc.'s retained earnings?: Biodesix, Inc. (BDSX) reported retained earnings of -$505.56M in Q1 2026.
How has Biodesix, Inc.'s retained earnings changed year-over-year?: Biodesix, Inc.'s retained earnings decreased by 6.7% year-over-year, from -$473.6M to -$505.56M.
What is the long-term trend for Biodesix, Inc.'s retained earnings?: Over 5 years (2020 to 2025), Biodesix, Inc.'s retained earnings has grown at a 14.0% compound annual growth rate (CAGR), from -$258.81M to -$497.76M.
What does retained earnings mean?: Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.